ORCID as entered in ROS
https://orcid.org/0000-0002-0490-7465
Select Publications
Conference Papers
, 2011, 'Socioeconomic gradients in cardiovascular risk factor prevalence and screening, and in knowledge of determinants of cardiovascular disease, in rural India', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702701215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'Nature of association between severe hypoglycaemia and risks of vascular events and death in ADVANCE', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, presented at
, 2010, 'Effects on Blood Pressure of a Low-Sodium, High-Potassium Salt Substitute Among Tibetan Chinese: A Randomized Controlled Trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, PEOPLES R CHINA, Beijing, pp. E353 - E353, presented at
, 2009, 'THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Sydney, pp. 1502 - 1502, presented at
, 2009, 'Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE', in DIABETOLOGIA, SPRINGER, AUSTRIA, Vienna, pp. S66 - S66, presented at
, 2009, 'THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S314 - S314, presented at
, 2009, 'THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, ITALY, Milan, pp. S179 - S179, presented at
, 2008, 'INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1115 - 1115, presented at
, 2008, 'JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. 1103 - 1103, presented at
, 2008, 'How many deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 603 - 603, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702503119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, pp. A121 - A121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652600086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2008, 'Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S189 - S189, presented at
, 2008, 'The intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): Results of the vanguard phase', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, GERMANY, Berlin, pp. S399 - S399, presented at
, 2008, 'Do we need to adjudicate major clinical events?', in Clinical Trials, pp. 56 - 60, http://dx.doi.org/10.1177/1740774507087972
, 2007, 'THE EFFICACY OF LOWER BLOOD PRESSURE GOALS ON THE PREVENTION OF STROKE IN CHRONIC KIDNEY DISEASE: DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A31 - A31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2007, 'Can NT-proBNP monitoring help prevent cardiovascular disease?', in Kimchi A (ed.), RECENT ADVANCES IN CARDIOVASCULAR DISEASE: PROCEEDINGS OF THE 13TH WORLD CONGRESS HEART DISEASE, MEDIMOND S R L, CANADA, Vancouver, pp. 331 - +, presented at
, 2006, 'The prevalence and management of diabetes in rural Indian adults', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 526 - 527, presented at
, 2006, 'THE PREDICTIVE ABILITY OF DIFFERENT MEASURES OF KIDNEY FUNCTION: NEW DATA FROM THE PROGRESS STUDY', in NEPHROLOGY, WILEY-BLACKWELL, pp. A46 - A46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'A low sodium, high potassium salt substitute substantially lowers blood pressure levels among high-risk individuals in rural northern China - The China Salt Substitute Study', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, pp. S150 - S151, presented at
, 2004, 'Lacunar stroke in PROGRESS study', in EUROPEAN JOURNAL OF NEUROLOGY, BLACKWELL PUBLISHING, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202992100093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2004, 'Effects of perindopril-based blood pressure lowering on the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Vancouver, pp. E285 - E285, presented at
, 2003, 'Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults - The InterASIA study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, HAWAII, HONOLULU, pp. E132 - E132, presented at
, 2002, 'Managing the global burden of cardiovascular disease', in European Heart Journal, Supplement, http://dx.doi.org/10.1016/S1520-765X(02)90022-2
, 2001, 'Blood pressure lowering in diabetes: A brief review of the current evidence and description of a new trial', in Clinical and Experimental Pharmacology and Physiology, pp. 1108 - 1111, http://dx.doi.org/10.1046/j.1440-1681.2001.03581.x
, 2001, 'Cardiovascular risk factors in a cohort of 3,499 Thais from 1985-1997', in EUROPEAN HEART JOURNAL, W B SAUNDERS CO LTD, pp. 714 - 714, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000170988302735&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2000, 'Blood pressure and stroke risk in Asia Pacific populations', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, pp. S25 - S25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000090000800127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1999, '1999 world health organization-international society of hypertension guidelines for the management of hypertension', in Journal of Hypertension, pp. 151 - 183, http://dx.doi.org/10.3109/10641969909061028
, 1999, '7th WHO-ISH Meeting on Hypertension, Fukuoka, Japan, 29 September to October, 1998: 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension', in Journal of Hypertension, pp. 151 - 183
, 1999, 'An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals', in Clinical and Experimental Hypertension, pp. 517 - 529, http://dx.doi.org/10.3109/10641969909060985
, 1998, '1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension', in CLINICAL AND EXPERIMENTAL HYPERTENSION, TAYLOR & FRANCIS INC, JAPAN, FUKUOKA, pp. 1009 - 1060, presented at
, 1998, 'PROGRESS: Perindopril protection against recurrent stroke study: Status in March 1997', in Journal of Human Hypertension, pp. 627 - 629, http://dx.doi.org/10.1038/sj.jhh.1000677
, 1997, 'Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease', in Clinical and Experimental Hypertension, pp. 843 - 855, http://dx.doi.org/10.3109/10641969709083190
, 1996, 'PROGRESS - perindopril protection against recurrent stroke study: Status in July 1996', in Journal of Hypertension, Supplement
, 1995, 'Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease', in Schweizerische Medizinische Wochenschrift, pp. 2479 - 2486
Conference Posters
, 2022, 'POS-392 CANAGLIFLOZIN TREATMENT IMPACTS COLLAGEN TYPE III DEGRADATION AND FORMATION IN THE CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT STUDY (CANVAS)', Vol. 7, pp. S177 - S177, http://dx.doi.org/10.1016/j.ekir.2022.01.414
, 2020, '1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-1130-p
, 2020, 'The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-139-LB
, 2020, 'EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION', Chicago, IL, Vol. 75, pp. 221 - 221, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), Chicago, IL, 28 March 2020 - 30 March 2020, http://dx.doi.org/10.1016/S0735-1097(20)30848-2
Conference Presentations
, 2022, '19-OR: KidneyIntelX Association with Clinical Outcomes in Diabetic Kidney Disease', http://dx.doi.org/10.2337/db22-19-or
, 2020, 'Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE', presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-26-OR
Conference Abstracts
, 2022, 'Substituting the world's salt supply', in Journal of Hypertension, Lippincott, Williams & Wilkins, JAPAN, Kyoto, Vol. 41, pp. E119 - E119, presented at 29th Scientific Meeting of the International Society of Hypertension (ISH), JAPAN, Kyoto, 12 October 2022 - 16 October 2022, http://dx.doi.org/10.1097/01.hjh.0000913896.40673.c0
, 2022, 'CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 15 - 15, http://dx.doi.org/10.26190/unsworks/28407
, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney outcome guided by HbA(1c) and predicted risk of kidney failure', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S278 - S278, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900548&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Novel subgroups of patients with type 2 diabetes show differential cardiovascular and kidney benefits with canagliflozin: a data-driven proteomic cluster analysis', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S132 - S132, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900252&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'The effect of salt substitution on headache: a cluster-randomized controlled trial', in CEPHALALGIA, SAGE PUBLICATIONS LTD, Vol. 42, pp. 61 - 62, http://dx.doi.org/10.26190/unsworks/28462
, 2022, 'EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, Vol. 79, pp. 1454 - 1454, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000781026601553&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Estimated Benefits And Risks Of Lowering Sodium Through Potassium-enriched Salt Substitution In India: A Modeling Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 145, http://dx.doi.org/10.1161/circ.145.suppl_1.019
, 2021, 'Heart failure therapies for the prevention of HER2-monoclonal antibody-mediated cardiotoxicity: A systematic review and meta-analysis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 119 - 119, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'The Impact of Australasian Voluntary Front of Pack Nutrition Labelling on Packaged Food Reformulation', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, Vol. 50, pp. 21 - 21, http://dx.doi.org/10.1093/ije/dyab168.050
, 2021, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial', in Diabetes, Obesity and Metabolism, Vol. 23, pp. 1652 - 1659, http://dx.doi.org/10.1111/dom.14386
Filter by type
https://orcid.org/0000-0002-0490-7465